menu

ReachMD

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Evolving Cervical Cancer Screening Options in Clinical Practice

Identify patients at risk earlier and reduce over-testing and unnecessary interventions.
  • Sponsored by

  • Overview

    In January 2016, the American College of Obstetricians and Gynecologists (ACOG) issued a Practice Bulletin providing guidance supporting the use of an FDA approved HPV test for first-line cervical cancer screening in women age 25 and older as an alternative to cytology. Increased understanding of the role of HPV in cervical cancer development has shed new light on how HPV testing can be integrated into cervical cancer screening, with the goal of identifying patients at risk earlier while reducing over-testing and unnecessary interventions.

    Join host, Dr. Renee Allen, as she interviews Dr. Lawrence Glad, Clinical Assistant Professor at the University of Pittsburgh, School of Medicine, to discuss recent guideline updates, the medical value of HPV primary screening and practical tips on how to successfully incorporate primary screening into clinician practice.

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.